
Bigatra 75mg Tablet
Marketer
Aprica Pharmaceuticals Pvt Ltd
Salt Composition
Dabigatran Etexilate (75mg)
Overview Bigatra 75mg Tablet
Trombax 75mg tablets function as an anticoagulant, preventing and treating blood clots. This medication lowers the risk of stroke and heart attack by inhibiting clot formation in leg, lung, brain, and heart veins. Frequently prescribed for patients with atrial fibrillation to prevent thrombi, it's also used post-knee or hip replacement to reduce clotting risk. While it can be taken with or without food, consistent daily timing is recommended. Long-term use, potentially lifelong, may be necessary; discontinuing or altering dosage without medical supervision significantly increases stroke, heart attack, or thrombosis risk. Lifestyle modifications—like healthy eating, exercise, weight management, and smoking cessation—complement this medication's effect in minimizing clot risk. Common side effects include gastrointestinal upset and increased bleeding tendency (e.g., nosebleeds, bruising). Report any adverse reactions promptly. Other potential side effects comprise headaches, seizures, allergic responses, visual disturbances, and fatigue. Contraindicated in individuals with severe hepatic or renal impairment, active bleeding, or concurrent use of other anticoagulants. Breastfeeding is not advised during treatment. Unlike some anticoagulants, routine PT-INR monitoring isn't mandated.
Primary Ingredients of Bigatra 75mg Tablet
No text provided to rephrase.
Uses of Bigatra 75mg Tablet
Preventing and managing blood clot formation.
Major Benefits of Bigatra 75mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 75mg Bigatra tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or not, although consistent timing is recommended.
Common Side effects of Bigatra 75mg Tablet:
- Nausea
- Anemia (low number of red blood cells)
- Gastrointestinal bleeding
- Dyspepsia
- Diarrhea
- Abdominal pain
- Nosebleeds
- Skin bleeding
How to use Bigatra 75mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Bigatra 75mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Bigatra 75mg Tablet works:
Coagulase inhibitor Bigatra 75mg tablets offer a new approach to oral anticoagulation, effectively hindering blood clot development.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Bigatra 75mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of Bigatra 75mg Tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the benefits against possible risks prior to prescribing. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Bigatra 75mg tablets are likely incompatible. Available evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Bigatra 75mg Tablet.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Bigatra 75mg Tablets, as dose modification may be necessary. Physician consultation is advised. Bigatra 75mg Tablets are generally unsuitable for individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Bigatra 75mg Tablets cautiously, as dose modification may be necessary. A physician's consultation is advised.
What if you forget to take Bigatra 75mg Tablet :
Should you forget a Bigatra 75mg Tablet dose, administer it as soon as you remember that day. However, omit the missed dose if ingestion is impossible within six hours of your next planned intake. Never compensate for a missed dose by doubling the subsequent one.
Facts to Know About Bigatra 75mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole compound |
| Developing Habits | No. |
| Treatment Category | Heart |
| Action Class | Oral direct thrombin inhibitor |
